Agj van der Zee
University Medical Center Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Agj van der Zee.
Cancer | 2002
J.A. de Hullu; Harry Hollema; Harald J. Hoekstra; Da Piers; Mje Mourits; Jan G. Aalders; Agj van der Zee
The objective of this study was to evaluate the authors recent, preliminary experience with the sentinel lymph node procedure in patients with vulvar melanoma and to compare this experience with treatment and follow‐up of patients with vulvar melanomas who were treated previously at their institution.
British Journal of Pharmacology | 2012
Evelien W. Duiker; Ecf Dijkers; H Lambers Heerspink; S de Jong; Agj van der Zee; Pl Jager; Jgw Kosterink; Ege de Vries; M. N. Lub-de Hooge
BACKGROUND AND PURPOSE The TNF‐related apoptosis inducing ligand (TRAIL) induces apoptosis through activation of the death receptors, TRAIL‐R1 and TRAIL‐R2. Recombinant human (rh) TRAIL and the TRAIL‐R1 directed monoclonal antibody mapatumumab are currently clinically evaluated as anticancer agents. The objective of this study was to develop radiopharmaceuticals targeting the TRAIL‐R1, suitable for clinical use to help understand and predict clinical efficacy in patients.
Scandinavian Journal of Gastroenterology | 2001
Mjw Berends; Ying Wu; Rolf H. Sijmons; Rmw Hofstra; Agj van der Zee; Chcm Buys; Jan H. Kleibeuker
Hereditary non-polyposis colorectal cancer is an autosomal dominant inherited disorder that predisposes its carriers to an almost 100% lifetime risk of cancer, in particular colorectal and endometrial cancer. Germline mutations, resulting in a deficient DNA mismatch repair system, are responsible for the disease. Because of the lack of specific phenotypical features, clinical diagnosis in an individual patient is impossible and relies heavily on family history. Genetic diagnosis by mismatch detection is now possible in a substantial proportion of families. Thus there is a great need for reliable but simple criteria that will help clinicians to recognize patients and families who can be referred for genetic diagnostics. In this article the different criteria that have been formulated and published in recent years are reviewed and the results, in terms of the proportions of subjects satisfying the criteria who were found to have a germline mutation, are discussed. In most studies the criteria were evaluated in only a small number of subjects. A population-based study is currently being carried out in the north of The Netherlands that aims to include 400 patients fulfilling one of a few simple criteria. Mutation analysis will be performed in all patients. The results of this study will help in the formulation of accurate and simple criteria for use in clinical practice.
British Journal of Obstetrics and Gynaecology | 2018
Annefloor W Pouwer; Rdm Mus; Joanna IntHout; Agj van der Zee; Johan Bulten; Lfag Massuger; J.A. de Hullu
To determine the efficacy of the addition of an ultrasound of the groins in routine follow up of women with vulvar squamous cell carcinoma (SCC) after a negative sentinel lymph node (SLN).
The Journal of Nuclear Medicine | 1998
J.A. de Hullu; E Doting; Da Piers; H. Hollema; Jg Aalders; Agj van der Zee; H. Schraffordt Koops; J. Boonstra
International Journal of Gynecological Cancer | 2006
Apg Crijns; Evelien W. Duiker; S de Jong; Phb Willemse; Agj van der Zee; Ege de Vries
International Journal of Oncology | 2003
G.B.A. Wisman; H. Hollema; Marco N. Helder; Aj Knol; Gt Van Der Meer; M. Krans; S de Jong; Ege de Vries; Agj van der Zee
Anticancer Research | 2004
Fyfl de Vos; A M E Bos; J. A. Gietema; Elisabeth Pras; Agj van der Zee; Ege de Vries; Phb Willemse
American Journal of Human Genetics | 2000
Ying Wu; Mjw Berends; Rgj Mensink; E Verlind; Rolf H. Sijmons; Agj van der Zee; Harry Hollema; Jan H. Kleibeuker; Chcm Buys; Rmw Hofstra
Anticancer Research | 1999
Gert-Jan Meersma; M Bakker; Hjm Groen; Agj van der Zee; Pb Jensen; G Giaccone; Ege de Vries; Ef Smit